Cita APA

Cieuta-Walti, C., Cuenca, A., Langohr, K., Dierssen, M., & De la Torre Fornell, R. (2022). Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome: A randomized phase Ib clinical trial (PERSEUS study).

Citación estilo Chicago

Cieuta-Walti, Cécile, Aida Cuenca, Klaus|||0000-0001-7075-9192 Langohr, Mara Dierssen, y Rafael De la Torre Fornell. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome: A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.

Cita MLA

Cieuta-Walti, Cécile, et al. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome: A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.